SHOULDER & ELBOW
No short-term benefit of PRP in arthroscopic rotator cuff repair
Sports Health. 2015 Jan;7(1):58-6625 patients with a rotator cuff tear <3cm, undergoing arthroscopic repair were randomized to one of two groups; a platelet rich plasma (PRP) group, which received intraoperative application of PRP along the repair site and a PRP injection at 4 weeks postoperatively, or a control group which received saline in a similar manner. Patients were followed up at 2, 4, and 6 weeks after surgery for pain, general and condition-specific quality of life, and disability. There were no significant differences between groups detected for change from baseline to 6 weeks in any outcome measure, and study enrollment was stopped early due to perceived lack of efficacy.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
